13F HOLDINGS REPORT
Pivotal bioVenture Partners Investment Advisor LLC
Quarter ended Q4 2024 · Filed February 13, 2025 · Accession 0001012975-25-000081
Total Value
$148.1M
Positions
11
Other Managers
1
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VAXCYTE INC | PCVX | 703,834 | $57.6M | 38.91% |
| 2 | OCULIS HOLDING AG | OCSAW | 1,737,696 | $29.5M | 19.95% |
| 3 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 2,120,508 | $29.5M | 19.95% |
| 4 | INOZYME PHARMA INC | 45790W108 | 4,494,851 | $12.5M | 8.41% |
| 5 | ZENAS BIOPHARMA INC | ZBIO | 736,645 | $6.0M | 4.07% |
| 6 | RECURSION PHARMACEUTICALS IN | RXRX | 595,518 | $4.0M | 2.72% |
| 7 | BIOAGE LABS INC | BIOA | 653,374 | $3.8M | 2.55% |
| 8 | RALLYBIO CORP | RLYB | 2,404,644 | $2.3M | 1.56% |
| 9 | BOLT BIOTHERAPEUTICS INC | BOLT | 1,891,467 | $1.0M | 0.69% |
| 10 | VIGIL NEUROSCIENCE INC | 92673K108 | 560,595 | $953,012 | 0.64% |
| 11 | IO BIOTECH INC | IOBT | 864,197 | $795,061 | 0.54% |